The Board granted service connection for esophageal cancer, benign prostate hypertrophy, and erectile dysfunction secondary to the now service-connected benign prostate hypertrophy. The claims for larynx cancer, peripheral neuropathy of the upper and lower extremities, diabetes, an acquired psychiatric disorder, and a stomach disorder were denied.

The deciding factor: The evidence supported a finding that the esophageal cancer, benign prostate hypertrophy, and erectile dysfunction were related to in-service herbicide exposure. However, there was no current diagnosis for larynx cancer or peripheral neuropathy, and further development is required for the other claims.

Claimed conditions

esophageal cancer, benign prostate hypertrophy, erectile dysfunction, larynx cancer, peripheral neuropathy of the bilateral upper extremities, peripheral neuropathy of the bilateral lower extremities

How they argued it

Not specified

Exposure basis

None

Rating assigned

None in this decision

Decision date

March 5, 2025

Citation

25003160

Want to see how appeals like this one tend to go? Appeals like mine